Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bayesian parameter estimation and population pharmacokinetics.

A H Thomson1, B Whiting

  • 1Department of Medicine and Therapeutics, Gardiner Institute, Western Infirmary, Glasgow, Scotland.

Clinical Pharmacokinetics
|June 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of amoxicillin, metronidazole and gentamicin dosage regimens for use in antibiotic prophylaxis in colorectal surgery.

The Journal of antimicrobial chemotherapy·2021
Same author

Pharmacokinetic/pharmacodynamic analysis of weight- and height-scaled tobramycin dosage regimens for patients with cystic fibrosis.

The Journal of antimicrobial chemotherapy·2019
Same author

SU-E-I-23: Effective Estimation of Focal Spot Isocenter for Sinograms Obtained with Flying Focal Spot Scans for Filtered Back Projection.

Medical physics·2017
Same author

Aminoglycosides: old friend…new foe?

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2016
Same author

Changing molecular profile of brain metastases compared with matched breast primary cancers and impact on clinical outcomes.

British journal of cancer·2016
Same author

The efficacy of aerosol treatment with non-ionic surfactant vesicles containing amphotericin B in rodent models of leishmaniasis and pulmonary aspergillosis infection.

Journal of controlled release : official journal of the Controlled Release Society·2012
Same journal

Population Pharmacokinetic Modelling of Dolutegravir: A Narrative Review.

Clinical pharmacokinetics·2026
Same journal

Partial Area Under the Curve: A Revelatory Story in Pharmacokinetics.

Clinical pharmacokinetics·2026
Same journal

Informing Sampling Design for Lung Distribution Studies Using a Pulmonary Population Minimal PBPK Model.

Clinical pharmacokinetics·2026
Same journal

Revisited Pharmacokinetic Profiles of Methylprednisolone in Plasma and Urine After Single and Multiple Oral Administrations: Relevance in Sports Drug Testing.

Clinical pharmacokinetics·2026
Same journal

ALBI Grade is a Determinant of Lenvatinib Pharmacokinetics, Efficacy, and Toxicities in Japanese Patients with Hepatocellular Carcinoma.

Clinical pharmacokinetics·2026
Same journal

Quantitative Pharmacology Justifying Ribociclib Dose in Early Breast Cancer.

Clinical pharmacokinetics·2026
See all related articles

Bayesian parameter estimation in therapeutic drug monitoring (TDM) requires robust population studies for accurate pharmacokinetic parameters. Large-scale studies are crucial for widely used drugs and neonatal TDM, enhancing drug safety and efficacy.

Area of Science:

  • Pharmacokinetics and Pharmacodynamics
  • Bayesian statistical modeling
  • Therapeutic Drug Monitoring (TDM)

Background:

  • Bayesian parameter estimation is increasingly used in TDM.
  • Prior pharmacokinetic parameter estimates are essential for Bayesian TDM.
  • Population studies are a key source for these estimates, often involving small subject groups.

Purpose of the Study:

  • To highlight the importance of population studies for Bayesian parameter estimation in TDM.
  • To discuss the application of Bayesian methods across various drug classes.
  • To explore future directions for Bayesian methods in pharmacokinetics and pharmacodynamics.

Main Methods:

  • Review of existing literature on Bayesian parameter estimation in TDM.
  • Analysis of the role of population studies in generating pharmacokinetic parameters.

Related Experiment Videos

  • Discussion of the extension of Bayesian methods to different drug types and study designs.

    • Main Results:

    • Population studies, especially large-scale ones, are vital for obtaining reliable pharmacokinetic parameters for Bayesian TDM, particularly for widely used drugs and neonatal populations.
    • Bayesian methods are effectively applied to drugs with narrow therapeutic ranges (e.g., aminoglycosides, cyclosporin) and have been extended to cytotoxic drugs, Factor VIII, and warfarin.
    • Bayesian approaches can reduce sample requirements in conventional pharmacokinetic studies.

    Conclusions:

    • Well-conducted population studies are fundamental for advancing Bayesian parameter estimation in TDM.
    • The application of Bayesian methods is expanding across diverse therapeutic areas.
    • Future research should integrate pharmacodynamic data into population studies for a comprehensive understanding of drug response and toxicity.